Association of chlamydial infection with cerebrovascular disease.

BACKGROUND AND PURPOSE Recent studies suggest an association of coronary heart disease and carotid atherosclerosis with Chlamydia pneumoniae infection. We investigated the frequency of chlamydial seropositivity and specific circulating immune complexes in patients with recent cerebrovascular disease. METHODS Specific antibodies to C pneumoniae in serum were measured by the microimmunofluorescence test in 58 consecutive patients (aged 18 to 50 years) with ischemic infarction (n = 39) or transient ischemic attacks (n = 19) and in 52 hospital control subjects without vascular disease, matched for sex, age, time, and locality. RESULTS Twenty-seven patients (46.6%) and 12 control subjects (23.1%) had raised IgA titers > or = 1:16 (P = .018). IgG titers > or = 1:32 were measured in 74.1% of the patients and 77% of control subjects (P = .623). Specific IgG antibodies in circulating immune complexes, which were isolated by polyethylene glycol precipitation, were elevated > or = 1:8 in 24.1% of the patients and 7.7% of control subjects (P = .047). With the use of a conditional logistic regression model, the odds ratios were 1.70 (95% confidence interval [CI], 1.13 to 2.58) for elevated IgA titers, 1.91 (95% CI, 1.06 to 3.47) for the presence of immune complexes, and 1.96 (95% CI, 1.00 to 3.82) for the presence of both factors. After adjustment for the vascular risk factors hypertension, age, sex, and migraine, the odds ratios were 1.71 (95% CI, 1.08 to 2.70), 2.00 (95% CI, 1.07 to 3.76), and 2.20 (95% CI, 1.09 to 4.41), respectively. CONCLUSIONS We conclude that chronic infection with C pneumoniae is associated with an increased risk of stroke and transient ischemic events.

[1]  D. Stewart,et al.  Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. , 1995, The Journal of infectious diseases.

[2]  Y. Goo,et al.  Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  D. Strachan,et al.  Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. , 1995, The Journal of infection.

[4]  H. Becher,et al.  Recent infection as a risk factor for cerebrovascular ischemia. , 1995, Stroke.

[5]  M. Leinonen,et al.  Chlamydia pneumoniae multiplies in human endothelial cells in vitro. , 1994, Microbial pathogenesis.

[6]  Y. Iijima,et al.  Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans , 1994, Journal of clinical microbiology.

[7]  T. Tuomi,et al.  Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test , 1994, Journal of clinical microbiology.

[8]  P. Saikku Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction. , 1993, European heart journal.

[9]  E. Benditt,et al.  Chlamydia pneumoniae, strain TWAR and atherosclerosis. , 1993, European heart journal.

[10]  M. Leinonen Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae. , 1993, European heart journal.

[11]  A. Folsom,et al.  Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators. , 1993, The American journal of medicine.

[12]  H. Fukushi,et al.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. , 1993, The Journal of infectious diseases.

[13]  J. Grayston Chlamydia in atherosclerosis. , 1993, Circulation.

[14]  M. Nieminen,et al.  Chlamydia Pneumoniae‐Specific Circulating Immune Complexes in Patients With Chronic Coronary Heart Disease , 1993, Circulation.

[15]  D. Siscovick,et al.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. , 1992, JAMA.

[16]  R. Snijder,et al.  Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor , 1992, Journal of clinical microbiology.

[17]  M. Leinonen,et al.  Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.

[18]  M. Golightly,et al.  Sequestration of antibody to Borrelia burgdorferi in immune complexes in seronegative Lyme disease , 1990, The Lancet.

[19]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[20]  M. Kaste,et al.  Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients , 1988, British medical journal.

[21]  J. Altman,et al.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. , 1986, The New England journal of medicine.

[22]  M. Leinonen,et al.  The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. , 1983, Science.